Literature DB >> 8949673

Contrast media as extracellular fluid space markers: adaptation of the central volume theorem.

P Dawson1, M J Blomley.   

Abstract

We present some theoretical observations on the pharmacokinetics of the conventional intravascular radiographic and gadolinium chelate MR contrast agents. These agents may be viewed from a physiological perspective as extracellular fluid (ECF) space markers. It can be shown that the passage of such agents through the body may be described by a variant of the "central volume theorem", if the central volume is taken to be that of the entire extracellular fluid. A consequence is that, in a manner akin to nuclear medicine techniques utilizing technetium-99m diethylene triamine pentacetic acid (DTPA), measures of glomerular filtration rate (GFR) related to total ECF volume rather than to the normal body surface area may be obtained from direct or indirect measurements of iodine or gadolinium plasma levels. Typical measurements are presented. A simple means is also described of generating curves of the fraction of contrast medium excreted from the body, applicable to both patients with normal and with abnormal renal function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8949673     DOI: 10.1259/0007-1285-69-824-717

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  2 in total

1.  MRI-CEST assessment of tumour perfusion using X-ray iodinated agents: comparison with a conventional Gd-based agent.

Authors:  Annasofia Anemone; Lorena Consolino; Dario Livio Longo
Journal:  Eur Radiol       Date:  2016-08-29       Impact factor: 5.315

Review 2.  Fluid balance concepts in medicine: Principles and practice.

Authors:  Maria-Eleni Roumelioti; Robert H Glew; Zeid J Khitan; Helbert Rondon-Berrios; Christos P Argyropoulos; Deepak Malhotra; Dominic S Raj; Emmanuel I Agaba; Mark Rohrscheib; Glen H Murata; Joseph I Shapiro; Antonios H Tzamaloukas
Journal:  World J Nephrol       Date:  2018-01-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.